Table 2 Operative and pathologic findings. DRM, distal resection margin.
DRM ≥ 1 cm (n = 418) | DRM < 1 cm (n = 89) | P | |
|---|---|---|---|
Type of operation | < 0.001 | ||
LAR | 286 (68.4%) | 35 (39.3%) | |
ISR | 105 (25.1%) | 54 (60.7%) | |
APR | 27 (6.5%) | - | |
LPND | 72 (17.2%) | 11 (12.4%) | 0.33 |
Tumor size, cm | 3.2 (2.0–4.5) | 2.5 (1.8–3.3) | < 0.001 |
Lymphovascular invasion | 32 (7.7%) | 3 (3.4%) | 0.22 |
Venous invasion | 32 (7.7%) | 4 (4.5%) | 0.41 |
Tumor perforation | 9 (2.2%) | 2 (2.2%) | 1.00 |
Pathologic stage | < 0.001 | ||
ypT0N0 | 45 (10.8%) | 21 (23.6%) | |
ypT0N + | 6 (1.4%) | - | |
I | 60 (14.4%) | 24 (27.0%) | |
II | 147 (35.2%) | 30 (33.7%) | |
III | 160 (38.3%) | 14 (15.7%) | |
CRM, positive (≤ 1 mm) | 40 (9.6%) | 8 (9.0%) | 1.00 |
Pathologic LPN positive | 23/72 (31.9%) | 2/11 (18.2%) | 0.57 |
Tumor regression grade | 0.002 | ||
0 (no regression) | 6 (1.5%) | 2 (2.3%) | |
1 (minor regression) | 52 (12.9%) | 8 (9.2%) | |
2 (moderate regression) | 144 (35.8%) | 15 (17.2%) | |
3 (good regression) | 149 (37.1%) | 41 (47.1%) | |
4 (total regression) | 51 (12.7%) | 21 (24.1%) |